Alex Frey is the Founding General Partner of Droplet VC, a U.S.-based VC, and a Mentor in accelerators and incubators at UC San Diego and others. He also serves on the Board of the Swiss-American Chamber of Commerce Southern California, where he builds cross-border partnerships to connect Swiss innovation with U.S. commercialization. With over a decade of experience across venture capital, biotech acceleration, and Swiss financial institutions, Alex is a multilingual venture builder and community leader passionate about advancing early-stage DeepTech innovation.

Dr. Danny Chatziprodromou holds a PhD in Computational Fluid Dynamics and Mechanical Engineering from ETH Zurich. He founded REOR20 in 2017 after working at Swiss Re and SAM Sustainable Asset Management. Through REOR20, he leads the development of next-generation flood-hazard models that are 100,000× faster and far more cost-effective than traditional approaches, leveraging AI and cutting-edge modeling to transform flood risk assessment.

Dr. Estelle Clerc is the founder and CEO of CellX Biosolutions, a Swiss cleantech startup developing bacterial solutions to break down persistent industrial pollutants such as PFAS, pesticides, and microplastics. Spinning out of her PhD at ETH Zurich, she has led the company to secure major funding, launch industry partnerships, and win the 2025 W.A. de Vigier Prize for entrepreneurial innovation.

As part of the Innovation Team, Oriane implements and expands entrepreneurship programs. Prior to joining Swissnex, Oriane worked in hotel and events management, as well as in the financial sector. She holds a BSc in International Hospitality Management from the EHL Hospitality Business School as well as an MSc in International Strategic Management from the University of Lund.